.After F2G's initial attempt to get a new lesson of antifungal to market was wrecked by the FDA, the...
.Moderna has vowed to reduce R&D spending by $1.1 billion through 2027. The selection to retract ...
.Simply 4 months after Sanofi wager $80 million in upfront money on Key Therapies' losmapimod, the c...
.Cancer provider Oncternal Therapeutics is folding all its own clinical trials and giving up team, t...
.Roche is keeping out hopes that its injectable obesity possibility can inevitably display 25% weigh...
.Novo Nordisk has elevated the top on a stage 1 test of its dental amylin and GLP-1 receptor co-agon...
.Simply a few brief full weeks after succeeding an FDA Fast lane tag for its investigational BTK deg...
.Not long after a favorable records decline for Eli Lilly's efsitora alfa, the Indianapolis-based fi...
.BridgeBio Pharma is actually slashing its genetics therapy budget as well as drawing back coming fr...
.GSK's try to establish the first injection for herpes simplex infection (HSV) has finished in faili...